JCM
ABBV icon

J2 Capital Management’s AbbVie ABBV Stock Holding History

J2 Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Buy
+7,224
New +$1.55M 1.22% 12

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

J2 Capital Management's ABBV Position: Q2 2026 in Review

J2 Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 7,224 shares worth $1.82M. The stake represents 1.22% of the portfolio and ranks #12 among its holdings.

986 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • J2 Capital Management held 7,224 shares of AbbVie worth $1.82M as of Q2 2026.
  • AbbVie was a new J2 Capital Management position in Q2 2026.
  • AbbVie made up 1.22% of J2 Capital Management's portfolio in Q2 2026, its #12 holding.
  • 986 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on J2 Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.